Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Liver international (Print)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 16420505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats.

  2005cited by this paper
• Selective inhibition of TGF-β responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP

  2005cited by this paper
• Inhibition of TGF- b signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis

  2005cited by this paper
• Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.

  2005cited by this paper
• Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration

  2005cited by this paper
• Application of RNAi to cancer research and therapy.

  2005cited by this paper
• Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease

  2005cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Effects of drug serum of anti-fibrosis I herbal compound on calcium in hepatic stellate cell and its molecular mechanism.

  2005cited by this paper
• TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.

  2005influential reference
• Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3

  2005cited by this paper
• The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis.

  2005cited by this paper
• Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.

  2005cited by this paper
• Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.

  2005cited by this paper
• Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

  2005cited by this paper
• Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.

  2005cited by this paper
• Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis.

  2005cited by this paper
• Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site.

  2004cited by this paper
• A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.

  2004cited by this paper
• Small interfering RNA (siRNA) targetted to Smad3 inhibits transforming growth factor-beta signaling.

  2004cited by this paper
• Blockage of transforming growth factor beta receptors prevents progression of pig serum-induced rat liver fibrosis.

  2004cited by this paper
• Targeted Disruption of TGF-β/Smad3 Signaling Modulates Skin Fibrosis in a Mouse Model of Scleroderma

  2004cited by this paper
• SB-505124 Is a Selective Inhibitor of Transforming Growth Factor- Type I Receptors ALK4, ALK5, and ALK7

  2004cited by this paper
• Transforming growth factor-beta-induced stimulation of formation of collagen fiber network and anti-fibrotic effect of taurine in an in vitro model of hepatic fibrosis.

  2004cited by this paper
• Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells.

  2004cited by this paper
• Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.

  2004cited by this paper
• Anti-TGFbeta1 antibody for modulation of expression of endogenous transforming growth factor beta 1 to prevent fibrosis after plastic surgery in rats.

  2004cited by this paper
• Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction.

  2004cited by this paper
• Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling.

  2004cited by this paper
• TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.

  2004cited by this paper
• Liver fibrosis

  2004cited by this paper
• Proteomic analysis of the TGF-beta signaling pathway in pancreatic carcinoma cells using stable RNA interference to silence Smad4 expression.

  2004cited by this paper
• TGF‐β signaling and the fibrotic response

  2004cited by this paper
• Nkx2.1 transcription factor in lung cells and a transforming growth factor‐β1 heterozygous mouse model of lung carcinogenesis

  2004cited by this paper
• Blockage of transforming growth factor β receptors prevents progression of pig serum-induced rat liver fibrosis

  2004cited by this paper
• Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-β-Mediated Pulmonary Fibrosis1

  2004cited by this paper
• Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis.

  2004cited by this paper
• Intrapleural injection of transforming growth factor-beta antibody inhibits pleural fibrosis in empyema.

  2004cited by this paper
• Inhibition of transforming growth factor β decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice

  2004cited by this paper
• Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.

  2004cited by this paper
• RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In vivo

  2004cited by this paper
• New insights into TGF-beta-Smad signalling.

  2004cited by this paper
• RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.

  2004cited by this paper
• Smad3 as a mediator of the fibrotic response

  2004influential reference
• Cyclin-dependent kinases regulate the antiproliferative function of Smads

  2004cited by this paper
• GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor

  2004influential reference
• SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.

  2004cited by this paper
• Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial–mesenchymal transition of lens epithelium in mice

  2004cited by this paper
• Liver fibrosis -- from bench to bedside.

  2003cited by this paper
• Add-On Anti – TGF-Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat

  2003cited by this paper
• Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.

  2003cited by this paper
• Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.

  2003cited by this paper
• Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• Preparation and identification of anti-transforming growth factor beta1 U1 small nuclear RNA chimeric ribozyme in vitro.

  2003cited by this paper
• Adenoviral expression of a transforming growth factor-β1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats

  2003cited by this paper
• Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus

  2003cited by this paper
• TGF-β signal transduction and mesangial cell fibrogenesis

  2003cited by this paper
• Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

  2003cited by this paper
• Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome

  2003cited by this paper
• SMAD2 and SMAD7 Involvement in the Post-translational Regulation of Muc4 via the Transforming Growth Factor-β and Interferon-γ Pathways in Rat Mammary Epithelial Cells*

  2003cited by this paper
• Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells.

  2003cited by this paper
• Molecular basis of hepatic fibrosis

  2003cited by this paper
• p38 MAPK mediates fibrogenic signal through smad3 phosphorylation in rat myofibroblasts

  2003influential reference
• Cross‐talk between ERK MAP kinase and Smad‐signaling pathways enhances TGF‐β dependent responses in human mesangial cells

  2003cited by this paper
• BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

  2003cited by this paper
• Preparation and identification of anti-transforming growth factor β1 U1 small nuclear RNA chimeric ribozyme in vitro

  2003cited by this paper
• The tightrope of therapeutic suppression of active transforming growth factor-beta: high enough to fall deeply?

  2003cited by this paper
• Modulation of renal glomerular disease using remote delivery of adenoviral‐encoded solubletype II TGF‐β receptor fusion molecule

  2003cited by this paper
• Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways.

  2003cited by this paper
• TGF-beta signal transduction and mesangial cell fibrogenesis.

  2003cited by this paper
• Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats.

  2003cited by this paper
• BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells

  2003cited by this paper
• SMAD2 and SMAD7 involvement in the post-translational regulation of Muc4 via the transforming growth factor-beta and interferon-gamma pathways in rat mammary epithelial cells.

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-β family signalling

  2003influential reference
• Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.

  2002cited by this paper
• Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats.

  2002cited by this paper
• Roles of TGF-beta in hepatic fibrosis.

  2002cited by this paper
• Inhibition of TGFβ1 by Anti-TGFβ1 Antibody or Lisinopril Reduces Thyroid Fibrosis in Granulomatous Experimental Autoimmune Thyroiditis1

  2002cited by this paper
• Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.

  2002cited by this paper
• Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable.

  2002cited by this paper
• A matrix for new ideas in pulmonary fibrosis.

  2002cited by this paper
• Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney.

  2002cited by this paper
• Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).

  2002cited by this paper
• Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease.

  2002cited by this paper
• Antihypertensive effects of chronic anti-TGF-β antibody therapy in Dahl S rats

  2002cited by this paper
• SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

  2002cited by this paper
• Blockade of the Effects of TGF-1 on Mesangial Cells by Overexpression of Smad 7

  2002cited by this paper
• Blockade of the effects of TGF-beta1 on mesangial cells by overexpression of Smad7.

  2002cited by this paper
• The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease.

  2002cited by this paper
• Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.

  2002cited by this paper
• Deficient Smad7 expression: A putative molecular defect in scleroderma

  2002cited by this paper
• Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor‐β in human umbilical vein endothelial cells

  2002cited by this paper
• RNA-mediated gene regulation system: now and the future (Review).

  2002cited by this paper
• Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors

  2002cited by this paper
• Inhibition of Transforming Growth Factor (TGF)- 1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF- Type I Receptor Kinase Activity: SB-431542

  2002cited by this paper
• Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

  2002cited by this paper
• Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.

  2001cited by this paper
• Molecular therapeutics of liver disease.

  2001cited by this paper
• Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

  2001cited by this paper

• Integrative multiomics analysis reveals the ameliorative effects of Xiasangju on metabolic dysfunction-associated steatohepatitis

  2026cites this paper
• p-Cymene inhibits pro-fibrotic and inflammatory mediators to prevent hepatic dysfunction

  2025cites this paper
• Clinical development complexity of TGF-β inhibition: From fibrosis to cancer immunotherapy.

  2025cites this paper
• pPB peptide-modified nanostructured lipid carriers loaded with astragaloside IV as a potential strategy for enhanced antifibrosis therapy.

  2025cites this paper
• Nrf2 alleviates excessive deposition of extracellular matrix in mammary fibrosis through TGF/Smad and ROS signals

  2025cites this paper
• Effect and mechanism of Nintedanib on acute and chronic radiation-induced lung injury in mice

  2025cites this paper
• m6A Modification Destabilizes Prss8 and Activates Hepatic Stellate Cells via TLR4-Mediated Inflammatory Responses

  2025cites this paper
• Bio fluid exosomes: promises, challenges, and future directions in translational medicine

  2025cites this paper
• Research Progress on the Mechanism of Baicalein in Scutellaria Baicalensis Against Liver Fibrosis

  2025cites this paper
• Thioamides in medicinal chemistry and as small molecule therapeutic agents.

  2024cites this paper
• Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk

  2024cites this paper
• Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells

  2024cites this paper
• Trimetazidine Alleviates Bleomycin-Induced Pulmonary Fibrosis by Targeting the Long Noncoding RNA CBR3-AS1-Mediated miRNA-29 and Resistin-Like Molecule alpha 1: Deciphering a Novel Trifecta Role of LncRNA CBR3-AS1/miRNA-29/FIZZ1 Axis in Lung Fibrosis

  2024cites this paper
• Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signaling

  2024cites this paper
• Ghrelin regulating liver activity and its potential effects on liver fibrosis and Echinococcosis

  2024cites this paper
• Structure-based design and synthesis of anti-fibrotic compounds derived from para-positioned 3,4,5-trisubstituted benzene.

  2024cites this paper
• Ghrelin is involved in regulating the progression of Echinococcus Granulosus-infected liver lesions through suppression of immunoinflammation and fibrosis

  2024cites this paper
• The Preventive and Therapeutic Potential of the Flavonoids in Liver Cirrhosis: Current and Future Perspectives

  2023cites this paper
• HOXC8/TGF-β1 positive feedback loop promotes liver fibrosis and hepatic stellate cell activation via activating Smad2/Smad3 signaling.

  2023cites this paper
• Effects of exosomes of mesenchymal stem cells on cholesterol-induced hepatic fibrogenesis

  2023cites this paper
• Transcriptional profiles of TGF-β superfamily members in the lumbar DRGs and the effects of activins A and C on inflammatory pain in rats

  2023cites this paper
• Suaeda glauca Attenuates Liver Fibrosis in Mice by Inhibiting TGFβ1-Smad2/3 Signaling in Hepatic Stellate Cells

  2023cites this paper
• Sacha inchi albumin delays skin-aging by alleviating inflammation, oxidative stress and regulating gut microbiota in D-Galactose induced aging mice.

  2023cites this paper
• Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK/ERK/S100A4 signalling pathway.

  2022cites this paper
• Exosomes of Whartons’ jelly mesenchymal stem cell reduce the NOX genes in TGF-β-induced hepatic fibrosis

  2022cites this paper
• PDGF-BB is involved in HIF-1α/CXCR4/CXCR7 axis promoting capillarization of hepatic sinusoidal endothelial cells

  2022cites this paper
• Transcriptional profiling of TGF-β superfamily members in lumbar DRGs of rats following sciatic nerve axotomy and activin C inhibits neuropathic pain.

  2022cites this paper
• HK1 from hepatic stellate cell–derived extracellular vesicles promotes progression of hepatocellular carcinoma

  2022cites this paper
• MicroRNA-181b promotes Schistosomiasis-induced Hepatic Fibrosis by targeting Smad7.

  2022cites this paper
• Effects of Isorhamnetin on Diabetes and Its Associated Complications: A Review of In Vitro and In Vivo Studies and a Post Hoc Transcriptome Analysis of Involved Molecular Pathways

  2022cites this paper
• Granulocyte-macrophage colony-stimulating factor (GM-CSF) shows therapeutic effect on dimethylnitrosamine (DMN)-induced liver fibrosis in rats

  2022cites this paper
• Oleanolic acid-loaded nanoparticles attenuate activation of hepatic stellate cells via suppressing TGF-β1 and oxidative stress in PM2.5-exposed hepatocytes.

  2022cites this paper
• TGFβ1-Pretreated Exosomes of Wharton Jelly Mesenchymal Stem Cell as a Therapeutic Strategy for Improving Liver Fibrosis

  2022cites this paper
• Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis

  2022cites this paper
• The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis

  2022cites this paper
• The Role of miR-29 Family in TGF-β Driven Fibrosis in Glaucomatous Optic Neuropathy

  2022cites this paper
• Comparison of the effects of cholesterol, palmitic acid, and glucose on activation of human hepatic stellate cells to induce liver fibrosis

  2022cites this paper
• Aspirin attenuates liver fibrosis by suppressing TGF-β1/Smad signaling

  2022cites this paper
• ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score

  2021cites this paper
• PM2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing TGF-β1.

  2021cites this paper
• Collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models

  2021cites this paper
• Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling

  2021cites this paper
• Interaction of non-parenchymal hepatocytes in the process of hepatic fibrosis

  2021cites this paper
• A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis

  2021cites this paper
• Latency-Associated Transcript-Derived MicroRNAs in Herpes Simplex Virus Type 1 Target SMAD3 and SMAD4 in TGF-β/Smad Signaling Pathway.

  2021cites this paper
• The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice

  2021cites this paper
• Updated Management and Prediction of Gastroesophageal Varices in Cirrhotic Patients

  2021cites this paper
• Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis.

  2021cites this paper
• Pulmonary inflammatory and fibrogenic response induced by graphitized multi-walled carbon nanotube involved in cGAS-STING signaling pathway.

  2021cites this paper
• TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop.

  2021cites this paper
• Protective effects of paclitaxel on thioacetamide‐induced liver fibrosis in a rat model

  2021cites this paper
• Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo

  2020cites this paper
• Total phenolic extract of Euscaphis konishii hayata Pericarp attenuates carbon tetrachloride (CCl4)-induced liver fibrosis in mice.

  2020cites this paper
• Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development

  2020cites this paper
• Hepatoprotective Potency of Chrysophanol 8-O-Glucoside from Rheum palmatum L. against Hepatic Fibrosis via Regulation of the STAT3 Signaling Pathway

  2020cites this paper
• Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair

  2020cites this paper
• The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol

  2020cites this paper
• Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice

  2020cites this paper
• Graptopetalum paraguayense Inhibits Liver Fibrosis by Blocking TGF-β Signaling In Vivo and In Vitro

  2019cites this paper
• Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells.

  2019cites this paper
• TGF-β1/p65/MAT2A pathway regulates liver fibrogenesis via intracellular SAM

  2019cites this paper
• Study on the association between TGF-β1 and liver fibrosis in patients with hepatic cystic echinococcosis

  2019cites this paper
• Deltamethrin induces liver fibrosis in quails via activation of the TGF-β1/Smad signaling pathway.

  2019cites this paper
• miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.

  2019cites this paper
• Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.

  2018cites this paper
• BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling

  2018cites this paper
• Parathyroid Hormone-Like Hormone Induces Epithelial-to-Mesenchymal Transition of Intestinal Epithelial Cells by Activating the Runt-Related Transcription Factor 2.

  2018cites this paper
• Curcumin Mitigates Radiation-induced Lung Pneumonitis and Fibrosis in Rats

  2018cites this paper
• The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis.

  2018cites this paper
• Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer

  2018cites this paper
• Swertiamarin ameliorates carbon tetrachloride-induced hepatic apoptosis via blocking the PI3K/Akt pathway in rats

  2018cites this paper
• Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location

  2018cites this paper
• Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer

  2018cites this paper
• The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis

  2018cites this paper
• miR-127 aggravates myocardial failure by promoting the TGF-β1/Smad3 signaling

  2018cites this paper
• Exploring the Mechanism of Dangguiliuhuang Decoction Against Hepatic Fibrosis by Network Pharmacology and Experimental Validation

  2018influential citation
• Food components with antifibrotic activity and implications in prevention of liver disease.

  2018cites this paper
• Identification of a host collagen inducing factor from the excretory secretory proteins of Trichinella spiralis

  2018cites this paper
• Bacterial Translocation Is Linked to Increased Intestinal IFN-γ, IL-4, IL-17, and mucin-2 in Cholestatic Rats.

  2018cites this paper
• Antifibrotic role of PGC‐1&agr;‐siRNA against TGF‐&bgr;1‐induced renal interstitial fibrosis

  2018cites this paper
• Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats

  2018cites this paper
• The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice

  2017cites this paper
• Effect of TGF-β/smad signaling pathway blocking on expression profiles of miR-335, miR-150, miR-194, miR-27a, and miR-199a of hepatic stellate cells (HSCs)

  2017cites this paper
• The Role of the Lysyl Oxidases in Tissue Repair and Remodeling: A Concise Review

  2017cites this paper
• Recovery of Vocal Fold Epithelium after Acute Phonotrauma

  2017cites this paper
• Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo

  2017cites this paper
• Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2

  2017cites this paper
• The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis

  2017influential citation
• Paraoxonase‐1 activity is related to Trichinella spiralis‐induced hepatitis in rats

  2017cites this paper
• Enhanced Wnt Signalling in Hepatocytes is Associated with Schistosoma japonicum Infection and Contributes to Liver Fibrosis

  2017cites this paper
• Hepatocyte-specific expression of constitutively active Alk5 exacerbates thioacetamide-induced liver injury in mice

  2017cites this paper
• Protective effects of Ampelopsis brevipedunculata against in vitro hepatic stellate cells system and thioacetamide-induced liver fibrosis rat model

  2017cites this paper
• Systemic inhibition of BMP1-3 decreases progression of CCl4-induced liver fibrosis in rats

  2017cites this paper
• TGF-β1 Induces EMT in Bovine Mammary Epithelial Cells Through the TGFβ1/Smad Signaling Pathway

  2017cites this paper
• Honokiol Alleviates Hypertrophic Scar by Targeting Transforming Growth Factor-β/Smad2/3 Signaling Pathway

  2017cites this paper
• Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis

  2017cites this paper
• Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling

  2017cites this paper
• Scoparone attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway.

  2017cites this paper
• Protective effects of theasinensin A against carbon tetrachloride-induced liver injury in mice.

  2017cites this paper
• Surface proteome analysis identifies platelet derived growth factor receptor-alpha as a critical mediator of transforming growth factor-beta-induced collagen secretion.

  2016cites this paper